Investment
Features
FeesSafety
Academy
More
Pluang+

Blackbaud launches Lantern, an AI tool tailored to boost fundraising for social impact organizations.

Market News
29 Sep 2026
PRNewsWire
View Source
Bullish
Blackbaud launches Lantern, an AI tool tailored to boost fundraising for social impact organizations.

Blackbaud introduced Lantern, the first AI language model specifically designed to enhance fundraising intelligence for social impact organizations. Developed in partnership with Databricks, Lantern leverages over 40 years of fundraising data to understand donor behavior and optimize fundraising strategies, addressing the gap where only 10% of organizations see significant AI returns. Lantern will be integrated into Blackbaud's Platform for Good, starting with select tools in 2027, aiming to help nonprofits raise more funds and increase their societal impact with AI tailored to their unique needs.

Blackbaud's launch of Lantern, an AI language model for fundraising, provides context for technology sector trends on Pluang. For readers following technology stocks, here is Pluang's market snapshot as of Sep 29, 2026 21:02 WIB: of 150 priced Technology-sector US stocks, 72 rose and 76 fell. Notable movers include AEHR at USD 104.89 with a 1-day change of +6.50%, ARM at USD 297.30 with +4.93%, and GLW at USD 157.79 with +4.15%. Typical hold times range from 14 to 35 days, with Pluang order activity showing varied buy/sell splits.

More News

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...

Analyst Insights
Bullish
1 hour ago
Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...

Market News
Bearish
1 hour ago
Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival Corporation reported strong quarterly results with earnings per share of $1.43 and net income of $1.92 billion, surpassing analyst expectations. The company achieved record revenue of $8.44 billion, driven by growing consumer interest in cru...

Company Fundamentals
Bullish
1 hour ago
FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet is set to report strong Q3 earnings with an expected EPS of $4.35 and revenue around $629.83 million, reflecting a 5.3% increase from last year. The company benefits from high demand for AI-related products, expanded client base, and effectiv...

Company Fundamentals
Bullish
1 hour ago
Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies Financial Group reported robust Q3 results with earnings per share of $1.09, beating analyst estimates and last year's $1.05. Revenue rose to $2.22 billion, driven by record banking revenue, surpassing expectations. Net earnings increased t...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App